[{"address1": "4930 Directors Place", "address2": "Suite 500", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 56, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 78, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 54, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 54, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Mann", "title": "Senior Vice President of Investor Relations & Corporate Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 47, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.58, "open": 8.47, "dayLow": 8.245, "dayHigh": 8.53, "regularMarketPreviousClose": 8.58, "regularMarketOpen": 8.47, "regularMarketDayLow": 8.245, "regularMarketDayHigh": 8.53, "payoutRatio": 0.0, "beta": 0.237, "forwardPE": -2.7667131, "volume": 1560693, "regularMarketVolume": 1560693, "averageVolume": 1511703, "averageVolume10days": 1383380, "averageDailyVolume10Day": 1383380, "bid": 8.4, "ask": 8.5, "bidSize": 1, "askSize": 1, "marketCap": 736168192, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 12.49, "allTimeHigh": 43.0, "allTimeLow": 2.5, "priceToSalesTrailing12Months": 7.076567, "fiftyDayAverage": 9.4999, "twoHundredDayAverage": 8.225125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 205969200, "profitMargins": -2.0848398, "floatShares": 63473188, "sharesOutstanding": 87017518, "sharesShort": 13626588, "sharesShortPriorMonth": 11310507, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1566, "heldPercentInsiders": 0.02128, "heldPercentInstitutions": 0.99254996, "shortRatio": 9.91, "shortPercentOfFloat": 0.15689999, "impliedSharesOutstanding": 87017518, "bookValue": 2.787, "priceToBook": 3.0355222, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -216884000, "trailingEps": -2.48, "forwardEps": -3.05778, "enterpriseToRevenue": 1.98, "enterpriseToEbitda": -0.862, "52WeekChange": 0.04070127, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 8.46, "targetHighPrice": 76.0, "targetLowPrice": 16.0, "targetMeanPrice": 32.45455, "targetMedianPrice": 28.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 549665024, "totalCashPerShare": 6.317, "ebitda": -238984992, "totalDebt": 19466000, "quickRatio": 4.828, "currentRatio": 5.117, "totalRevenue": 104029000, "debtToEquity": 8.026, "revenuePerShare": 1.19, "returnOnAssets": -0.26569998, "returnOnEquity": -0.65099996, "grossProfits": -120284000, "freeCashflow": -104869872, "operatingCashflow": 87800000, "grossMargins": -1.15625, "ebitdaMargins": -2.29729, "operatingMargins": -3.8552802, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": -0.11820602, "postMarketPrice": 8.45, "postMarketChange": -0.010000229, "regularMarketChange": -0.12, "regularMarketDayRange": "8.245 - 8.53", "corporateActions": [], "postMarketTime": 1771625278, "regularMarketTime": 1771621202, "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.3986, "regularMarketPrice": 8.46, "marketState": "CLOSED", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1511703, "fiftyTwoWeekLowChange": 3.0500002, "fiftyTwoWeekLowChangePercent": 0.56377083, "fiftyTwoWeekRange": "5.41 - 12.49", "fiftyTwoWeekHighChange": -4.0299997, "fiftyTwoWeekHighChangePercent": -0.32265812, "fiftyTwoWeekChangePercent": 4.070127, "earningsTimestampStart": 1772112600, "earningsTimestampEnd": 1772112600, "earningsCallTimestampStart": 1762261200, "earningsCallTimestampEnd": 1762261200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.48, "epsForward": -3.05778, "epsCurrentYear": -2.71333, "priceEpsCurrentYear": -3.11794, "fiftyDayAverageChange": -1.0398998, "fiftyDayAverageChangePercent": -0.109464295, "twoHundredDayAverageChange": 0.23487473, "twoHundredDayAverageChangePercent": 0.028555762, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]